Conscious that it needed a drug pipeline to survive as a drug company, Bayer has made deals with cutting-edge firms like genomics leaders Curagen and Millennium Pharmaceuticals , as well Avigen , a gene therapy company, and Lion Bioscience , a biotech computing company.
FORBES: Bayer's Bitter Pill